Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Sherlock Biosciences
40 Guest Street, 3rd Floor
Boston, MA 02135
Phone: 617-612-8209
https://sherlock.bio/

Powered by CRISPR and synthetic biology, Sherlock's proprietary engineering biology tools form the foundation of its decentralized diagnostic platform for DNA and RNA detection. In 2020 the company made history with the first FDA-authorized use of CRISPR technology.

Key Contact
Name
Bryan Dechairo
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
03/10/22 $80,000,000 Series B Albany Capital
Catalio Capital
Good Ventures
Illumina Ventures
Northpond Ventures
Novalis LifeSciences
undisclosed